top of page

myLaminin Perspectives


ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now
ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Deanne Bassili
May 74 min read
bottom of page